Form 8-K · Current report
Dover Corporation 8-K, filed Oct 22, 2026
- Filed
- CIK
- 0000029905
- Accession no.
- 0000029905-26-000032
Summary
Dover Corporation reported third-quarter 2026 revenue of $2.23 billion, up 8% from a year earlier, and GAAP diluted EPS from continuing operations of $2.50, up 14%. Dover guided full-year 2026 GAAP EPS to $8.93–$9.08 and adjusted EPS to $10.60–$10.75, with revenue growth of 7%–8%.
Key points
- Q3 2026 organic revenue grew 7%; adjusted earnings from continuing operations were $388 million, up 7%.
- Nine-month revenue was $6.48 billion, up 8% (+6% organic), and GAAP diluted EPS from continuing operations was $6.56, up 10%.
- CEO Richard J. Tobin said bookings increased across all five segments and again outpaced shipments, with a significant portion of backlog scheduled for delivery in 2027.
- Dover repurchased more than $330 million of its shares during the quarter and announced two bolt-on acquisitions.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition. On October 22, 2026, Dover Corporation ("Dover") issued the Press Release attached hereto as Exhibit 99.1 announcing its results of operations for the quarter ended September 30, 2026. The information in this Current Report on Form 8-K, including Exhibit 99.1, is being furnished to the Securities and Exchange Commission (the “SEC”) and shall not be deemed to be incorporated by reference into any of Dover’s filings with the SEC under the Securities Act of 1933, as amended. Item 7.01 Regulation FD Disclosure. As previously announced, on October 22, 2026, Dover will hold an investor conference call and webcast at 8:30 a.m. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.